Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Pénaranda

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|February 13, 2007
[Noninvasive methods for predicting liver fibrosis in patients with chronic hepatitis C: alternatives to liver biopsy]Philippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
World Journal of Hepatology|June 10, 2017
Usefulness of the MESH score in a European hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
Annales De Biologie Clinique|April 17, 2014
[Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France]Hacène Khiri, Claire Camus, Mireille Portugal, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Journal of Medical Virology|December 24, 2005
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infectionPhilippe Halfon, Guillaume Pénaranda, Marc Bourlière, et al.
Journal of Clinical Medicine|August 4, 2015
High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with MenPatrick Philibert, Hacène Khiri, Guillaume Pénaranda, et al.
World Journal of Hepatology|September 21, 2020
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Clinical and Translational Gastroenterology|December 14, 2022
Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French CohortAnne Plauzolles, Stella Uras, Guillaume Pénaranda, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|February 13, 2007
[Noninvasive methods for predicting liver fibrosis in patients with chronic hepatitis C: alternatives to liver biopsy]Philippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
World Journal of Hepatology|June 10, 2017
Usefulness of the MESH score in a European hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
Annales De Biologie Clinique|April 17, 2014
[Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France]Hacène Khiri, Claire Camus, Mireille Portugal, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Journal of Medical Virology|December 24, 2005
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infectionPhilippe Halfon, Guillaume Pénaranda, Marc Bourlière, et al.
Journal of Clinical Medicine|August 4, 2015
High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with MenPatrick Philibert, Hacène Khiri, Guillaume Pénaranda, et al.
World Journal of Hepatology|September 21, 2020
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Clinical and Translational Gastroenterology|December 14, 2022
Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French CohortAnne Plauzolles, Stella Uras, Guillaume Pénaranda, et al.
Pageof 5